Not everyone is working with OWS, and there are general opportunities related to coronaviruses. See, e.g.,
https://www.vbivaccines.com/coronavirus/
In September I attended a webinar with CBO of that company along with a Board member of Novavax and the CFO of Emergent Biosolutions.
From a vaccine standpoint, there are apparently myriad global opportunities, and many (perhaps most or all) extend well beyond 2021.
We are just at the beginning of understanding aspects of many possible futures with regard to this somebeetch virus and others (perhaps its cousins) that humankind may encounter.